Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-27, Stock:NVS, The news for the past five days is as follows:
2018-07-20: NEWS1: Pfizer gets FDA approval for drug similar to Amgen&apos;s Neupogen.NEWS2: Top Research Reports for Microsoft, Novartis & Goldman Sachs.NEWS3: Top Research Reports for Microsoft, Novartis & Goldman Sachs.NEWS4: Merck to Cut Price of Few Drugs Amid Drug Pricing Controversy.NEWS5: Merck to Cut Price of Few Drugs Amid Drug Pricing Controversy.NEWS6: Bullish Two Hundred Day Moving Average Cross - NVS.NEWS7: Bullish Two Hundred Day Moving Average Cross - NVS.NEWS8: Swiss, German drugmakers join U.S. price freeze.NEWS9: Top Research Reports for Microsoft, Novartis & Goldman Sachs.NEWS10: Swiss, German drugmakers join U.S. price freeze.NEWS11: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, FDA Approvals.NEWS12: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, FDA Approvals.NEWS13: Pharma Stock Roundup: JNJ & NVS&apos; Q2 Earnings, FDA Approvals.NEWS14: Swiss, German drugmakers join U.S. price freeze.NEWS15: The Swiss Stock Market Climbed Despite Trade Worries.NEWS16: The Swiss Stock Market Climbed Despite Trade Worries.NEWS17: Three Key Takeaways From Healthcare Earnings Season.NEWS18: Free Post Earnings Research Report: Novartis’ Net Sales Jumped 7%; Non-GAAP EPS Advanced 6%.NEWS19: Valsartan Drugs Recalled Over Potential Carcinogen Contamination.NEWS20: Valsartan Drugs Recalled Over Potential Carcinogen Contamination.NEWS21: Novartis' (NVS) Kisqali Gets FDA Nod for Label Expansion.NEWS22: Novartis' (NVS) Kisqali Gets FDA Nod for Label Expansion.NEWS23: Roche's Tecentriq Met Primary Goal in First-Line NSCLC Study.NEWS24: Roche's Tecentriq Met Primary Goal in First-Line NSCLC Study.
2018-07-23: NEWS1: What's in the Cards for Glaxo (GSK) This Earnings Season?.NEWS2: What's in the Cards for Glaxo (GSK) This Earnings Season?.NEWS3: What&apos;s in the Cards for Glaxo (GSK) This Earnings Season?.NEWS4: Amgen (AMGN) to Report Q2 Earnings: Will it Beat Again?.NEWS5: Amgen (AMGN) to Report Q2 Earnings: Will it Beat Again?.NEWS6: BIIB, LLY Q2 Earnings on Jul 24: Here are the Key Predictions.NEWS7: BIIB, LLY Q2 Earnings on Jul 24: Here are the Key Predictions.NEWS8: Novartis’s Innovative Medicines Segment in Q2 2018.NEWS9: Should GlaxoSmithKline Break Up?.NEWS10: Should GlaxoSmithKline Break Up?.NEWS11: Tilray’s IPO Looks Badly Overpriced – And It Might Not Matter.NEWS12: The Zacks Analyst Blog Highlights: Microsoft, Novartis, Goldman Sachs, Starbucks and General Motors.NEWS13: The Zacks Analyst Blog Highlights: Microsoft, Novartis, Goldman Sachs, Starbucks and General Motors.NEWS14: Novartis in Q2 2018: Segment Performances.NEWS15: Should GlaxoSmithKline Break Up?.NEWS16: The Zacks Analyst Blog Highlights: Microsoft, Novartis, Goldman Sachs, Starbucks and General Motors.NEWS17: Novartis’s Q2 2018 Revenue Growth.NEWS18: The Swiss Stock Market Dropped At The Start Of The Trading Week.NEWS19: The Swiss Stock Market Dropped At The Start Of The Trading Week.
2018-07-24: NEWS1: Biogen Stock Trending Higher on Strong Q2 2018 Results.NEWS2: Lilly (LLY) Tops Q2 Earnings, Chooses IPO Path for Elanco.NEWS3: Lilly (LLY) Tops Q2 Earnings, Chooses IPO Path for Elanco.NEWS4: Novartis's Cultural Revolution Will Be AI-Enabled and Desk-Free.NEWS5: Novartis’s Key Developments in July.NEWS6: Novartis’s Q2 2018 Earnings: Alcon.NEWS7: The Swiss Stock Market Climbed On Bank Strength.NEWS8: The Swiss Stock Market Climbed On Bank Strength.NEWS9: Novartis’s Q2 2018 Earnings: Sandoz.NEWS10: J&J’s Oncology Franchise Saw 42.2% Growth in Q2 2018.
2018-07-25: NEWS1: Why AnaptysBio Rose 10.5% Today.NEWS2: Why AnaptysBio Rose 10.5% Today.NEWS3: Why AnaptysBio Rose 10.5% Today.NEWS4: Gilead's Earnings Fail to Impress.NEWS5: Glaxo (GSK) Beats on both Earnings and Revenue in Q2.NEWS6: Did This Top Biotech Stock Just Go on Sale?.NEWS7: Did This Top Biotech Stock Just Go on Sale?.NEWS8: The Swiss Stock Market Rose Slightly On Roche Strength.NEWS9: The Swiss Stock Market Rose Slightly On Roche Strength.NEWS10: Novartis’s Valuation after Its Q2 2018 Earnings.
2018-07-26: NEWS1: Wall Street Analysts Estimate a Decline in Sanofi’s Adjusted EPS in Q2.NEWS2: Could Sanofi’s Sales Decline Again in Q2 2018?.NEWS3: Celgene Raises Revenue Guidance after Solid Growth in Q2 2018.NEWS4: Glaxo (GSK) Q2 Earnings & Sales Beat Estimates, '18 View Up.NEWS5: Glaxo (GSK) Q2 Earnings & Sales Beat Estimates, '18 View Up.NEWS6: Gilead (GILD) Q2 Earnings & Sales Beat Eclipsed by CEO Exit.NEWS7: Gilead (GILD) Q2 Earnings & Sales Beat Eclipsed by CEO Exit.NEWS8: The Swiss Stock Market Jumped On Broad Strength.NEWS9: The Swiss Stock Market Jumped On Broad Strength.NEWS10: Initiating Free Research Reports on Pfizer and Three Other Drug Makers Equities.NEWS11: Omeros Announces Voluntary Dismissal Of Infringement Suit Against Sandoz.NEWS12: Omeros Announces Voluntary Dismissal Of Infringement Suit Against Sandoz.NEWS13: Biotech Stocks Facing FDA Decision In August.NEWS14: Biotech Stocks Facing FDA Decision In August.

Answer: Rise